Clinical Trial

Study on Drug Interactions Affecting the Pharmacokinetics of RSS0343 Tablet

Name: Study on Drug Interactions Affecting the Pharmacokinetics of RSS0343 Tablet — clinical trial record (NCT07696091)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study is a single-center, single-sequence, self-controlled, open design, aiming to investigate the effects of rifampicin and clarithromycin on the pharmacokinetics of RSS0343 in humans.

Trial Details

NCT Number	NCT07696091
Lead Sponsor	Reistone Biopharma Company Limited
Conditions	Non-cystic Fibrosis Bronchiectasis、Chronic Sinusitis Without Nasal Polyps、Chronic Obstructive Pulmonary Disease
Enrollment	40 participants
Start Date	2026-07
Primary Completion	2026-09 (estimated)
Study Completion	2026-09 (estimated)
Updated on ClinicalTrials.gov	2026-07-10